Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Depreciation & Amortization (CF) (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Depreciation & Amortization (CF) for 17 consecutive years, with $977.0 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 48.03% to $977.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 billion through Dec 2025, down 58.22% year-over-year, with the annual reading at $4.0 billion for FY2025, 58.22% down from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $977.0 million at Bristol Myers Squibb, down from $1.0 billion in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $2.7 billion in Q3 2021, with the low at $977.0 million in Q4 2025.
  • Average Depreciation & Amortization (CF) over 5 years is $2.2 billion, with a median of $2.5 billion recorded in 2022.
  • The sharpest move saw Depreciation & Amortization (CF) grew 7.71% in 2021, then crashed 61.06% in 2025.
  • Over 5 years, Depreciation & Amortization (CF) stood at $2.6 billion in 2021, then dropped by 2.25% to $2.5 billion in 2022, then dropped by 2.26% to $2.5 billion in 2023, then fell by 23.7% to $1.9 billion in 2024, then plummeted by 48.03% to $977.0 million in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $977.0 million, $1.0 billion, and $1.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.